Alpha MOS fell sharply on the Paris Bourse on Tuesday, after reporting a widening of its first-half losses, against a backdrop of inflationary pressures and investments aimed at developing its business with key accounts.

Over the first six months of the year, the industrial group's operating loss widened to 1.5 million euros from -1.2 million euros a year earlier.

Its net loss stood at over two million euros, compared with a shortfall of 1.3 million euros at the end of the first half of 2022.

Sales for the first half of the year rose by 14% to 2.7 billion euros.

While the manufacturer of artificial noses has confirmed its objective of organic sales growth for the current year, the Group's short-term cash position is a matter "that calls for a degree of caution", point out Euroland analysts.

With 784,000 euros in available cash, Alpha MOS itself acknowledges that it does not have sufficient resources to finance its operational development plan over the next twelve months.

In this context, the company says it is considering various hypotheses to strengthen its financial structure, giving priority in particular to obtaining external financing.

Although Euroland's analysts have lowered their price target on the stock from three to 2.5 euros, they are reiterating their "buy" recommendation on the share, saying they are "very positive" on the encouraging results obtained in the "medtech" activity and the commercial momentum of the "foodtech" business.

With losses of 26%, Alpha MOS shares posted the biggest drop on the Paris market on Tuesday following this publication.

Copyright (c) 2023 CercleFinance.com. All rights reserved.